FDA 483 - Ionetix Corporation - February 09, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Ionetix Corporation, a PET drug manufacturer in Miami, FL, was cited for significant deficiencies across its quality systems during an FDA inspection. Observations included inadequate contamination prevention in cleanrooms, improper equipment installation affecting airflow, and failures in approving specifications and following quality assurance procedures for material release and expiration dating. These issues indicate a lack of robust controls to ensure product quality and purity.
ID · d7f7f5da-4201-4047-9492-4884f1eba635